The FSC has granted TAIFEX recognition as a QCCP ahead of the launch, which will boost capital efficiency for market participants.
June 17, 2022The new contracts are a response to heightened market demand for industry-specific risk management tools, TAIFEX says.
June 14, 2022Margin levels on equity index, commodity, FX and ETF contracts will be raised by 10 percent from 26 January.
January 24, 2022TAIFEX will also replace its older trading system equipment by Q4 2022 to improve trading efficiency, market capacity and service delivery.
January 14, 2022in 2022, Asia derivatives market growth will be driven by ESG-related products and increased retail investor participation.
December 21, 2021TAIFEX said the financial industry is the most interesting sector to foreign investors in Taiwan's stock market.
December 10, 2021FSC chairman Huang Tien-mu said it is "imperative" to establish central clearing for OTC derivatives as soon as possible.
July 15, 2021Biotech is the third largest sector by trading value in Taiwan’s stock market. TAIFEX TIP Taiwan BIO Futures can now be offered and sold to US persons.
January 26, 2021The roadmap aims to promote ESG development, establish operational rules to enable central clearing for OTC derivatives, and boost fundraising in the capital markets.
December 9, 2020TAIFEX says the QCCP status will help attract more foreign and institutional investors to participate in Taiwan's futures market.
December 4, 2020